Literature DB >> 2809905

Substrate disposal in metabolic disease: a comparison between rates of in vivo propionate oxidation and urinary metabolite excretion in children with methylmalonic acidemia.

G N Thompson1, J H Walter, J L Bresson, G C Ford, J P Bonnefont, R A Chalmers, J M Saudubray, J V Leonard, D Halliday.   

Abstract

The relative importance of endogenous metabolism and urinary metabolite excretion was assessed in vivo in six children with methylmalonic acidemia by examining the kinetics of the immediate precursor to methylmalonate, propionate. Total production and oxidation of propionate were measured by means of a continuous infusion of (1-13C)propionate and were compared with the urinary excretion of propionate metabolites. Propionate oxidation was substantial (mean 48.9 mumol/kg/hr +/- SD 18.0) and, in four children, exceeded urinary metabolite excretion (mean urinary excretion in all subjects 40 mumol/kg/hr +/- 25). The sum of urinary excretion and oxidation rates (88 mumol/kg/hr +/- 29) approximated the total propionate production (93.4 +/- 37.0), suggesting that these routes together constitute the major mechanisms of propionate disposal. These results suggest that propionate oxidation is an important route of disposal in methylmalonic acidemia. Variations in the relative proportions of propionate disposal through oxidation and urinary excretion may be one reason for the often poor correlation between clinical status and urinary metabolite excretion. Measurement of urinary metabolite concentration alone may not always reflect clinical status and responses to treatment accurately.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2809905     DOI: 10.1016/s0022-3476(89)80651-1

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  4 in total

1.  Plasma total odd-chain fatty acids in the monitoring of disorders of propionate, methylmalonate and biotin metabolism.

Authors:  M Coker; J B de Klerk; B T Poll-The; J G Huijmans; M Duran
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

2.  On the differences between urinary metabolite excretion and odd-numbered fatty acid production in propionic and methylmalonic acidaemias.

Authors:  U Wendel; A Eissler; W Sperl; P Schadewaldt
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

3.  Metabolic phenotype of methylmalonic acidemia in mice and humans: the role of skeletal muscle.

Authors:  Randy J Chandler; Jennifer Sloan; Hong Fu; Matthew Tsai; Sally Stabler; Robert Allen; Klaus H Kaestner; Haig H Kazazian; Charles P Venditti
Journal:  BMC Med Genet       Date:  2007-10-15       Impact factor: 2.103

4.  1-13C-propionate breath testing as a surrogate endpoint to assess efficacy of liver-directed therapies in methylmalonic acidemia (MMA).

Authors:  Irini Manoli; Alexandra R Pass; Elizabeth A Harrington; Jennifer L Sloan; Jack Gagné; Samantha McCoy; Sarah L Bell; Jacob D Hattenbach; Brooks P Leitner; Courtney J Duckworth; Laura A Fletcher; Thomas M Cassimatis; Carolina I Galarreta; Audrey Thurm; Joseph Snow; Carol Van Ryzin; Susan Ferry; Nicholas Ah Mew; Oleg A Shchelochkov; Kong Y Chen; Charles P Venditti
Journal:  Genet Med       Date:  2021-04-05       Impact factor: 8.822

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.